These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21766634)

  • 41. Medical implications of hyperuricemia.
    Sachs L; Batra KL; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):353-5. PubMed ID: 19999892
    [No Abstract]   [Full Text] [Related]  

  • 42. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
    Dalbeth N; Merriman T
    Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gout].
    Carey Berner I; Dudler J
    Rev Med Suisse; 2006 Jan; 2(48):160-2. PubMed ID: 16463802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.
    Nakagawa T; Tuttle KR; Short RA; Johnson RJ
    Nat Clin Pract Nephrol; 2005 Dec; 1(2):80-6. PubMed ID: 16932373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term remission from gout associated with fenofibrate therapy.
    Hepburn AL; Kaye SA; Feher MD
    Clin Rheumatol; 2003 Feb; 22(1):73-6. PubMed ID: 12605325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hyperuricemia and kidney failure].
    Hosoya T
    Nihon Naika Gakkai Zasshi; 2006 Mar; 95(3):544-9. PubMed ID: 16640090
    [No Abstract]   [Full Text] [Related]  

  • 47. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout.
    Krishnan E
    Rheumatology (Oxford); 2010 Jul; 49(7):1229-38. PubMed ID: 20202928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gout: a clinical syndrome illustrated and discussed.
    Bhansing KJ; van Bon L; Janssen M; Radstake TR
    Neth J Med; 2010 Sep; 68(9):352-9. PubMed ID: 20876915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gout: an independent risk factor for all-cause and cardiovascular mortality.
    Kuo CF; See LC; Luo SF; Ko YS; Lin YS; Hwang JS; Lin CM; Chen HW; Yu KH
    Rheumatology (Oxford); 2010 Jan; 49(1):141-6. PubMed ID: 19933595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Chronic kidney diseases and various other diseases: 7. Hyperuricemia].
    Ono I; Hosoya T
    Nihon Naika Gakkai Zasshi; 2007 May; 96(5):922-7. PubMed ID: 17564084
    [No Abstract]   [Full Text] [Related]  

  • 52. [Tophaceous gout in plurimetabolic syndrome].
    Iannello S; Cavaliere G; Ferro G; Giuffrì MV; Impellizzieri D; Incognito C; Lizzio G; Neri S; Rapisarda A; Belfiore F
    Minerva Med; 1998; 89(11-12):419-37. PubMed ID: 10212666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hyperuricemia as a unique marker for metabolic syndrome].
    Nakajima H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():269-73. PubMed ID: 15779385
    [No Abstract]   [Full Text] [Related]  

  • 54. Primary prevention in rheumatology: the importance of hyperuricemia.
    Vázquez-Mellado J; Alvarez Hernández E; Burgos-Vargas R
    Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):111-24. PubMed ID: 15121034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gouty arthritis. A primer on late-onset gout.
    Ene-Stroescu D; Gorbien MJ
    Geriatrics; 2005 Jul; 60(7):24-31. PubMed ID: 16026179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fructose-induced hyperuricemia in healthy subjects and in patients with gout and secondary hyperuricemia].
    Matzkies F; Berg G
    Med Welt; 1974 Mar; 25(10):414-5. PubMed ID: 4820429
    [No Abstract]   [Full Text] [Related]  

  • 57. [2 cases of co-existing gout and myeloproliferative syndrome].
    RICHTER R
    Orv Hetil; 1961 Jul; 102():1473-5. PubMed ID: 13741414
    [No Abstract]   [Full Text] [Related]  

  • 58. [I. Metabolic disease: 2. Hyperuricemia and chronic kidney disease].
    Hosoya T; Ohno I
    Nihon Naika Gakkai Zasshi; 2011 May; 100(5):1206-12. PubMed ID: 21702135
    [No Abstract]   [Full Text] [Related]  

  • 59. Coexistence of gout and metabolic craniopathy.
    FEIRING W
    N Y State J Med; 1946 Mar; 46():631-4. PubMed ID: 21019388
    [No Abstract]   [Full Text] [Related]  

  • 60. Fructus Gardenia Extract ameliorates oxonate-induced hyperuricemia with renal dysfunction in mice by regulating organic ion transporters and mOIT3.
    Hu QH; Zhu JX; Ji J; Wei LL; Miao MX; Ji H
    Molecules; 2013 Jul; 18(8):8976-93. PubMed ID: 23899832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.